Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin P Howden

Showing results (261-270 of 376) with videos related to

Pageof 38
Sort By:
Nature Communications|October 14, 2023
Cryptic susceptibility to penicillin/β-lactamase inhibitor combinations in emerging multidrug-resistant, hospital-adapted Staphylococcus epidermidis lineagesXiaoliang Ba, Claire L Raisen, Olivier Restif, et al.
Trials|April 1, 2016
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trialSteven Y C Tong, Jane Nelson, David L Paterson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2019
Unstable chromosome rearrangements in <i>Staphylococcus aureus</i> cause phenotype switching associated with persistent infectionsRomain Guérillot, Xenia Kostoulias, Liam Donovan, et al.
Cell Reports|September 13, 2023
A statistical genomics framework to trace bacterial genomic predictors of clinical outcomes in Staphylococcus aureus bacteremiaStefano G Giulieri, Romain Guérillot, Natasha E Holmes, et al.
Peerj|March 8, 2017
Genomic analysis of ST88 community-acquired methicillin resistant <i>Staphylococcus aureus</i> in GhanaGrace Kpeli, Andrew H Buultjens, Stefano Giulieri, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremiaNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
The Medical Journal of Australia|April 3, 2020
Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in AustraliaLeon Caly, Julian Druce, Jason Roberts, et al.
Plos Pathogens|November 22, 2011
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKRBenjamin P Howden, Christopher R E McEvoy, David L Allen, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2018
Genomic Analysis of Multiresistant Staphylococcus capitis Associated with Neonatal SepsisGlen P Carter, James E Ussher, Anders Gonçalves Da Silva, et al.
Microbial Genomics|April 24, 2026
The <i>Escherichia coli</i> F plasmidome: an Australian perspectiveMax L Cummins, Anne E Watt, Celeste M Donato, et al.
Pageof 38

Showing results (261-270 of 376) with videos related to

Sort By:
Pageof 38
Nature Communications|October 14, 2023
Cryptic susceptibility to penicillin/β-lactamase inhibitor combinations in emerging multidrug-resistant, hospital-adapted Staphylococcus epidermidis lineagesXiaoliang Ba, Claire L Raisen, Olivier Restif, et al.
Trials|April 1, 2016
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trialSteven Y C Tong, Jane Nelson, David L Paterson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2019
Unstable chromosome rearrangements in <i>Staphylococcus aureus</i> cause phenotype switching associated with persistent infectionsRomain Guérillot, Xenia Kostoulias, Liam Donovan, et al.
Cell Reports|September 13, 2023
A statistical genomics framework to trace bacterial genomic predictors of clinical outcomes in Staphylococcus aureus bacteremiaStefano G Giulieri, Romain Guérillot, Natasha E Holmes, et al.
Peerj|March 8, 2017
Genomic analysis of ST88 community-acquired methicillin resistant <i>Staphylococcus aureus</i> in GhanaGrace Kpeli, Andrew H Buultjens, Stefano Giulieri, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremiaNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
The Medical Journal of Australia|April 3, 2020
Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in AustraliaLeon Caly, Julian Druce, Jason Roberts, et al.
Plos Pathogens|November 22, 2011
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKRBenjamin P Howden, Christopher R E McEvoy, David L Allen, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2018
Genomic Analysis of Multiresistant Staphylococcus capitis Associated with Neonatal SepsisGlen P Carter, James E Ussher, Anders Gonçalves Da Silva, et al.
Microbial Genomics|April 24, 2026
The <i>Escherichia coli</i> F plasmidome: an Australian perspectiveMax L Cummins, Anne E Watt, Celeste M Donato, et al.
Pageof 38